Atherogenic & Residual Risk Pathway

Evaluation of Lp(a], ApoB/ApoA1 ratio, hsCRP, and Homocysteine to guide therapeutic escalation in patients with premature or unexplained cardiovascular risk. · v1.3
How to use this tool: For patients whose presentation is not explained by LDL-C and the standard 10-year risk equations, such as premature disease or a strong family history. Enter whatever biomarkers are available and the tool will synthesise the profile.

Patient Context

Advanced Lipidology

Inflammation & Endothelium

Advanced Lipidology & Risk Enhancers

Practice Pearl: Avoiding Unnecessary Expense
Do not repeatedly test Lipoprotein(a). Lp(a) levels are overwhelmingly genetically determined and remain stable throughout a patient's life. Standard statins do not lower it. It should be measured once in a lifetime to establish baseline genetic risk; sequential testing is a financial burden without clinical utility.
1. The "ALIGN" Mnemonic for Residual Risk

When standard lipid panels fail to explain clinical presentation, think ALIGN: ApoB/ApoA1 ratio, Lp(a), Inflammation (hsCRP), Genetics (Family Hx), Nutrition (Homocysteine/B12).

2. The ApoB/ApoA1 Ratio (The INTERHEART Anchor)

Relying solely on LDL-C can be highly misleading, particularly in South Asian patients who often have small, dense LDL particles. ApoB provides a direct measure of the total number of atherogenic particles, while ApoA1 reflects protective HDL capacity. A ratio > 0.9 in men (or > 0.8 in women) signifies a highly atherogenic phenotype requiring aggressive intervention.

3. Lipoprotein(a): The Genetic Intercept

Lp(a) is highly atherogenic and pro-thrombotic. Values > 50 mg/dL indicate profound, independent risk. When elevated, respond by driving the patient's ApoB/LDL-C down to exceedingly low targets (per Lipid Association of India guidelines) to mitigate aggregate risk.

4. Homocysteine & Endothelial Dysfunction

Elevated homocysteine is frequently driven by B12 and folate deficiencies secondary to strict vegetarian diets in the Indian subcontinent. Recognising elevated homocysteine allows correction of the underlying nutritional deficit to address a parallel vector of vascular damage.

Category Advanced DiagnosticsPathway
Specialties Internal Medicine, Cardiology
Written and maintained by Dr Shashikiran Umakanth.
Last revised: 8 August 2026